Yixiao Liu
Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China
Beijing, 100021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Plasma proteomic and metabolomic profiling reveals molecular features relevant to neoadjuvant therapy response in locally advanced esophageal squamous cell carcinoma.
Journal: Molecular cancer
Published: January 14, 2026
RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling.
Journal: Cancer letters
Published: December 12, 2025
CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications.
CCL20-CCR6 axis in autoimmune disease and cancer progression: clinical and therapeutic implications.
Journal: Cell communication and signaling : CCS
Published: November 01, 2025
KRASG12V/A146T mutations are associated with nCRT resistance via enhanced DNA double-strand break repair and support a deep learning prediction framework in LARC.
Journal: Cellular & molecular biology letters
Published: September 26, 2025
RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy.
Journal: Cancer letters
Published: July 29, 2025
Neutrophils in cancer: At the crucial crossroads of anti-tumor and pro-tumor.
Journal: Cancer communications (London, England)
Published: September 19, 2024
Regulatory T cells in immune checkpoint blockade antitumor therapy.
Journal: Molecular cancer
Published: July 13, 2024
Targeting LSD1 in cancer: Molecular elucidation and recent advances.
Journal: Cancer letters
Published: May 09, 2024
Prognostic model for predicting the survival benefit of adjuvant chemotherapy for elderly patients with stage II colon cancer: a population-based study.
Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
Published: February 01, 2024
Showing 1-10 of 10
Last Updated: 09/26/2026